PUBLISHER: The Business Research Company | PRODUCT CODE: 1949778
PUBLISHER: The Business Research Company | PRODUCT CODE: 1949778
Appetite control and suppressants refer to methods, substances, or strategies used to manage hunger and reduce the urge to eat, supporting weight management. These approaches include natural methods such as consuming high-fiber or high-protein foods, staying hydrated, and maintaining regular sleep and stress patterns, as well as medical or pharmaceutical interventions that suppress appetite.
The main product types of appetite control and suppressants include prescription appetite suppressants, over-the-counter (OTC) appetite suppressants, natural or herbal suppressants, meal replacements and shakes, and dietary fiber supplements. Prescription appetite suppressants are medications prescribed by healthcare professionals to help curb hunger or cravings and support weight loss. These products are available in forms such as tablets, capsules, powders, gummies, chews, liquids, and bars. They are distributed through pharmacies, drugstores, supermarkets, hypermarkets, online retailers, specialty stores, and healthcare providers or clinics, serving a wide range of end-users, including adults, adolescents, and the elderly.
Tariffs have influenced the appetite control and suppressants market by raising costs for herbal extracts, pharmaceutical ingredients, and nutritional inputs used in prescription, OTC, and natural appetite suppressants. Meal replacements, fiber supplements, and herbal product segments are most impacted, especially in North America and Asia-Pacific where imports dominate sourcing. Positively, tariffs are driving local sourcing of botanicals and in-country supplement manufacturing, strengthening regional supply chains.
The appetite control and suppressants market research report is one of a series of new reports from The Business Research Company that provides appetite control and suppressants market statistics, including appetite control and suppressants industry global market size, regional shares, competitors with a appetite control and suppressants market share, detailed appetite control and suppressants market segments, market trends and opportunities, and any further data you may need to thrive in the appetite control and suppressants industry. This appetite control and suppressants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The appetite control and suppressants market size has grown strongly in recent years. It will grow from $3.84 billion in 2025 to $4.11 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to obesity prevalence, dietary supplement demand, lifestyle changes, fitness awareness, otc product availability.
The appetite control and suppressants market size is expected to see strong growth in the next few years. It will grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to weight management awareness, natural supplement preference, digital wellness platforms, preventive healthcare focus, aging population. Major trends in the forecast period include rising demand for weight management solutions, growth of natural and herbal suppressants, expansion of otc appetite control products, increased focus on lifestyle-based weight loss, growth of online and direct-to-consumer sales.
The rising prevalence of overweight and obesity is expected to drive the growth of the appetite control and suppressants market in the coming years. Overweight and obesity are conditions characterized by excessive body fat accumulation that can negatively impact health. The increase in these conditions is primarily due to high-calorie diets rich in sugars and unhealthy fats, combined with insufficient nutrient intake and sedentary lifestyles. Appetite control and suppressants help manage overweight and obesity by reducing hunger signals, limiting calorie intake, and supporting effective weight management. For example, in September 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that in 2023, 23 states had adult obesity prevalence of 35% or higher, and all 50 states recorded obesity rates of at least 20%. Therefore, the rising rates of overweight and obesity are fueling growth in the appetite control and suppressants market.
Key companies in the appetite control and suppressants market are focusing on innovative products, such as natural appetite suppressant drinks, to provide safer and more effective weight management solutions. Natural appetite suppressant drinks are beverages formulated from herbs, fruits, or fibers that naturally reduce hunger and control cravings. For instance, in December 2024, Nestle S.A., a Switzerland-based food and beverage company, launched Boost Pre-Meal Hunger Support, a natural appetite suppressant drink. Designed to mimic the effects of GLP-1-based medications like Ozempic and Wegovy, this 45-calorie, 10-gram whey protein shot is intended to be consumed 10-30 minutes before meals. It stimulates the body's natural GLP-1 hormone response to reduce appetite and increase satiety, using fast-digesting peptides and whey protein microgels to extend fullness, making it ideal for individuals following weight-loss plans or GLP-1-based treatments.
In January 2024, Roche Holding AG, a Switzerland-based multinational healthcare company, acquired Carmot Therapeutics for USD 2.7 billion. Through this acquisition, Roche aims to expand its portfolio in obesity and metabolic disease therapeutics by integrating Carmot's clinical and preclinical assets, including dual GLP-1/GIP receptor agonists, and leveraging its Chemotype Evolution discovery platform to accelerate the development of innovative appetite control and weight-management therapies. Carmot Therapeutics Inc., based in the US, is a biotech company specializing in novel therapeutics for obesity, diabetes, and other metabolic disorders.
Major companies operating in the appetite control and suppressants market are Nestle S.A, GlaxoSmithKline plc, Sanofi S.A, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Herbalife Nutrition Ltd, Amway Corporation, GNC Holdings Inc., Medifast Inc., Nature's Sunshine Products Inc., The Boots Company PLC, BPI Sports LLC, Grenade (UK) Limited, Currax Pharmaceuticals LLC, VIVUS Inc, Orexigen Therapeutics Inc, NOW Health Group Inc, Nutrabay Retail Private Limited, GAT Sport
North America was the largest region in the appetite control and suppressants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the appetite control and suppressants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the appetite control and suppressants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The appetite control and suppressants market consist of sales of thermogenic appetite suppressants, serotonin-based appetite suppressants, fat binders, stimulant-free appetite suppressants, lipase inhibitors, glucomannan-based supplements, and garcinia cambogia-based products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Appetite Control And Suppressants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses appetite control and suppressants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for appetite control and suppressants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The appetite control and suppressants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.